Approximately 60% of cases of atypical hemolytic uremic syndrome are associated with deficiencies of the complement regulatory protein, including mutations in complement factor H, complement factor I, or the membrane co-factor protein. The gene discussed is CFH; the disease is atypical hemolytic-uremic syndrome.